Applies to the following strength(s): 68 mg
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Contraception
One 68 mg implant inserted subdermally. The implant should not be left in place more than three years.
The timing of insertion must be done according to the patient's recent history, as follows:
If no preceding hormonal contraceptive use in the past month, the implant must be inserted between Days 1 through 5, (counting the first day of menstruation as "Day 1"), even if the woman is still bleeding.
If switching from a combination hormonal contraceptive, the implant may be inserted anytime within seven days after the last active (estrogen plus progestin) oral contraceptive tablet, anytime during the seven-day ring-free period of NuvaRing (etonogestrel/ethinyl estradiol vaginal ring), or anytime during the seven-day patch-free period of a transdermal contraceptive system.
If switching from a progestin-only method, the implant must inserted as follows: if switching from a progestin-only pill, any day of the month (do not skip any days between the last pill and insertion); if switching from a progestin-only implant, insert the implant on the same day as contraceptive implant removal; if switching from a progestin-containing IUD, insert the implant on the same day as contraceptive implant removal; if switching from a contraceptive injection, insert the implant on the day when the next injection would be due.
Following first trimester abortion or miscarriage: the implant may be inserted immediately following a complete first trimester abortion. If it is not inserted within five days following a first trimester abortion, follow the instructions under no preceding hormonal contraceptive use in the past month.
Following delivery or a second trimester abortion: the implant may be inserted between 21 to 28 days postpartum if not exclusively breast feeding or between 21 to 28 days following second trimester abortion. If more than four weeks have elapsed, pregnancy should be excluded and the patient should use a non-hormonal method of birth control during the first seven days after the insertion. If the patient is exclusively breast-feeding, insert the implant after the fourth postpartum week.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
The use of etonogestrel implant is contraindicated in patients with active liver disease.
Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.